Canntab Therapeutics Limited announced that it has appointed Larry Latowsky as CEO effective immediately. Originally appointed as an Advisor to the Company, it was mutually decided that Mr. Latowsky's extensive experience and connections in wholesale, retail and direct to consumer pharmaceutical industries would be an essential ingredient to the operations of the company and accordingly the board of directors decided to appoint Larry as CEO.